Healthcare - Biotechnology - NASDAQ - US
$ 1.5884
4.5 %
$ 41.2 M
Market Cap
-4.96
P/E
INCOME STATEMENT
0
REVENUE
-8.31 M
OPERATING INCOME
-8.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Anebulo Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 8.31 M |
| Operating Income | -8.31 M |
| Other Expenses | -107 K |
| Net Income | -8.2 M |
Income Statement
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 8.3 | 11.8 | 6.8 | 3.6 | 0.2 |
| Selling, General and Administrative Expenses | 4.8 | 6.2 | 3.9 | 1.3 | 23.4 K |
| Research and Development Expenses | 3.5 | 5.6 | 3.0 | 2.3 | 0.1 |
| Operating Income | (8.3) | (11.8) | (6.8) | (3.6) | (0.2) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.2 | 0 | 7.33 K | 11.8 K | 1.29 K |
| Total Other Income | 0.1 | 51.3 K | 5.56 K | (26.6) | 1.29 K |
| Pre-Tax Income | (8.2) | (11.7) | (6.8) | (30.3) | (0.2) |
| NET INCOME | |||||
| Tax Provision | 0 | (0.1) | 12.9 K | 10.7 K | 1.04 K |
| Net Income | (8.2) | (11.7) | (6.8) | (30.3) | (0.2) |
| EPS | 0.32 | 0.47 | 0.29 | 1.3 | 0.0074 |